BRAF and colorectal carcinoma: Blocking this phosphorylation, by disrupting endosomal V-ATPase, reduced growth, and metastasis of mutant BRAF xenografts in mice [137], suggesting that this previously unknown pathway could be targeted in CRC, specifically targeting p45-IKK or their associated endosomes.